Journal article · 2023 · Open access
Development and validation of a psoriasis treatment acceptability measure through group concept mapping
Health and Quality of Life Outcomes, 21(1), 83 · Published 8 August 2023 · DOI 10.1186/s12955-023-02162-6
In brief
“Development and validation of a psoriasis treatment acceptability measure through group concept mapping” is a 2023 journal article by Stacie A. Hudgens and 4 co-authors, published in Health and Quality of Life Outcomes. OpenAlex counts 3 citations as of 22 November 2026. It is open access under a CC BY licence: the full text is free to read at Health and Quality of Life Outcomes.
- Citations
- 3
- Most cited in
- 2026 (2)
- Field-weighted impact
- 0.27
- References
- 48
- Authors
- 5
Abstract
BACKGROUND: Psoriasis is a common autoimmune dermatologic condition which has a pronounced negative impact on patient quality of life and disease burden. Currently, there are a number of treatments available for psoriasis, with differences in efficacy, mechanism of action, mode of administration, adverse effects, and tolerability. However, a reliable, validated patient-reported instrument to address patient expectations and of psoriasis treatment has not been developed. This project was undertaken with the aim of developing a fit-for-purpose self-reported instrument to inform patient expectations and preferences of psoriasis treatments. METHODS: Two studies, both utilizing qualitative and quantitative methods, were conducted in patients within the entire spectrum of psoriasis severity. In Study 1, a group concept mapping (GCM) exercise was conducted with dermatologists and moderate-to-severe psoriasis patients to identify concepts important in the treatment of psoriasis. In Study 2, a preliminary Treatment Acceptability Questionnaire (TAQ) was developed using GCM-derived concepts from Studies 1 and 2, followed by cognitive debriefing (CD) telephone interviews of the preliminary TAQ. In Study 2, another GCM exercise was conducted with mild and newly diagnosed psoriasis patients. Psychometric analyses were performed on the TAQ to evaluate validity and reliability. RESULTS: The Study 1 GCM exercise generated 43 concepts from moderate-to-severe psoriasis patients (n = 20) and dermatologists (n = 10). In Study 2, 37 GCM concepts were generated from mild and newly diagnosed psoriasis patients (n = 20). From the 2 GCM exercises, 28 concepts were selected to form the preliminary TAQ; CD interviews indicated strong understanding and relevance of TAQ items among patients with disease ranging from mild to severe. The final TAQ consisted of 20 items; psychometric analysis demonstrated strong validity and reliability of the TAQ. CONCLUSIONS: The TAQ is a novel psychometrically validated patient-reported instrument to inform healthcare providers of patients' expectations of and preferences for treatment of their psoriasis and can help in shared decision making between patients and physicians.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Hudgens, S. A., Howerter, A., Keith, S., Evans, C. C., & Pelletier, C. L. (2023). Development and validation of a psoriasis treatment acceptability measure through group concept mapping. Health and Quality of Life Outcomes, 21(1), 83. https://doi.org/10.1186/s12955-023-02162-6
MLA 9
Hudgens, Stacie A., et al. “Development and validation of a psoriasis treatment acceptability measure through group concept mapping.” Health and Quality of Life Outcomes, vol. 21, no. 1, 2023, p. 83. https://doi.org/10.1186/s12955-023-02162-6.
Chicago
Hudgens, Stacie A., Amy Howerter, Shannon Keith, Colby C Evans, and Corey L. Pelletier. 2023. “Development and validation of a psoriasis treatment acceptability measure through group concept mapping.” Health and Quality of Life Outcomes 21 (1): 83. https://doi.org/10.1186/s12955-023-02162-6.
Harvard
Hudgens, S. A. et al. (2023) ‘Development and validation of a psoriasis treatment acceptability measure through group concept mapping’, Health and Quality of Life Outcomes, 21(1), p. 83. doi:10.1186/s12955-023-02162-6.
IEEE
S. A. Hudgens, A. Howerter, S. Keith, C. C. Evans, and C. L. Pelletier, “Development and validation of a psoriasis treatment acceptability measure through group concept mapping,” Health and Quality of Life Outcomes, vol. 21, no. 1, p. 83, 2023, doi: 10.1186/s12955-023-02162-6.
BibTeX
@article{hudgens2023development,
title = {{Development and validation of a psoriasis treatment acceptability measure through group concept mapping}},
author = {Hudgens, Stacie A. and Howerter, Amy and Keith, Shannon and Evans, Colby C and Pelletier, Corey L.},
journal = {Health and Quality of Life Outcomes},
year = {2023},
volume = {21},
number = {1},
pages = {83},
doi = {10.1186/s12955-023-02162-6},
url = {https://doi.org/10.1186/s12955-023-02162-6}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- psoriasis
- treatment acceptability
- patient-reported outcomes
- group concept mapping
- patient expectations
- treatment preferences
- shared decision-making
- psychometric validation
Work with this paper
Most-cited papers in Immunology and Microbiology
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Ulrich K. Laemmli · Nature · 1970 · 249,784 citations
- Atherosclerosis — An Inflammatory DiseaseRussell Ross · New England Journal of Medicine · 1999 · 21,957 citations
- Continuous cultures of fused cells secreting antibody of predefined specificityGeorges Köhler, César Milstein · Nature · 1975 · 17,450 citations
- Inflammation and cancerLisa M. Coussens, Zena Werb · Nature · 2002 · 15,462 citations
- Dendritic cells and the control of immunityJacques Banchereau, Ralph M. Steinman · Nature · 1998 · 14,526 citations
Questions about this paper
How do I cite this paper in APA style?
Hudgens, S. A., Howerter, A., Keith, S., Evans, C. C., & Pelletier, C. L. (2023). Development and validation of a psoriasis treatment acceptability measure through group concept mapping. Health and Quality of Life Outcomes, 21(1), 83. https://doi.org/10.1186/s12955-023-02162-6
How many times has this paper been cited?
3 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Health and Quality of Life Outcomes: sign in and open the PDF from this page.
Who wrote this paper?
Stacie A. Hudgens, Amy Howerter, Shannon Keith, Colby C Evans, Corey L. Pelletier.
What is the DOI of this paper?
10.1186/s12955-023-02162-6, permanently at https://doi.org/10.1186/s12955-023-02162-6. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.